Mid-Atlantic Division
CHTN_PrC_Prog1 - Prostate Cancer Tumor Progression
TMA Map
Code Key
Tissue List
TMA code | Diagnosis | Age | Race | pT stage* | Grade (Gleason Score)† | AMACR staining | K903 Staining | |
N1 | Normal non-neoplastic protate epithelium | 57 | W | |||||
N2 | Normal non-neoplastic protate epithelium | 62 | B | |||||
N3 | Normal non-neoplastic protate epithelium | 56 | W | |||||
N4 | Normal non-neoplastic protate epithelium | 48 | W | |||||
N5 | Normal non-neoplastic protate epithelium | 53 | W | |||||
N6 | Normal non-neoplastic protate epithelium | 64 | W | |||||
N7 | Normal non-neoplastic protate epithelium | 63 | B | |||||
N8 | Normal non-neoplastic protate epithelium | 54 | B | |||||
N9 | Normal non-neoplastic protate epithelium | 54 | W | |||||
N10 | Normal non-neoplastic protate epithelium | 59 | W | |||||
BPH1 | Benign prostatic hyperplasia | 76 | W | |||||
BPH2 | Benign prostatic hyperplasia | 58 | W | |||||
BPH3 | Benign prostatic hyperplasia | 67 | W | |||||
BPH4 | Benign prostatic hyperplasia | 66 | W | |||||
BPH5 | Benign prostatic hyperplasia | 53 | W | |||||
BPH6 | Benign prostatic hyperplasia | 64 | W | |||||
BPH7 | Benign prostatic hyperplasia | 71 | B | |||||
BPH8 | Benign prostatic hyperplasia | 57 | W | |||||
BPH9 | Benign prostatic hyperplasia | 65 | O | |||||
BPH10 | Benign prostatic hyperplasia | 60 | W | |||||
PIN1 | Prostatic Intraepithelial neoplasia, High Grade | 54 | B | Weak Positive | Positive | |||
PIN2 | Prostatic Intraepithelial neoplasia, High Grade | 59 | W | Positive | Positive | |||
PIN3 | Prostatic Intraepithelial neoplasia, High Grade | 64 | W | Positive | Positive | |||
PIN4 | Prostatic Intraepithelial neoplasia, High Grade | 54 | W | Positive | Positive | |||
PIN5 | Prostatic Intraepithelial neoplasia, High Grade | 67 | W | Positive | Positive | |||
PIN6 | Prostatic Intraepithelial neoplasia, High Grade | 59 | W | Positive | Positive | |||
PIN7 | Prostatic Intraepithelial neoplasia, High Grade | 67 | W | Positive | Positive | |||
PIN8 | Prostatic Intraepithelial neoplasia, High Grade | 64 | W | Positive | Positive | |||
PIN9 | Prostatic Intraepithelial neoplasia, High Grade | 56 | B | Positive | Positive | |||
PIN10 | Prostatic Intraepithelial neoplasia, High Grade | 58 | W | Positive | Positive | |||
Ca-A1 | Primary invasive adenocarcinoma, Gleason score 5-6 | 58 | W | pT2c | 3+3=6 | |||
Ca-A2 | Primary invasive adenocarcinoma, Gleason score 5-6 | 56 | W | pT2c | 3+3=6 | |||
Ca-A3 | Primary invasive adenocarcinoma, Gleason score 5-6 | 52 | W | pT3a | 3+3=6 | |||
Ca-A4 | Primary invasive adenocarcinoma, Gleason score 5-6 | 66 | W | pT2c | 3+3=6 | |||
Ca-A5 | Primary invasive adenocarcinoma, Gleason score 5-6 | 53 | W | pT2c | 3+3=6 (TERTIARY PATTERN 4) | |||
Ca-A6 | Primary invasive adenocarcinoma, Gleason score 5-6 | 59 | W | pT2c | 3+3=6 (TERTIARY PATTERN 4) | |||
Ca-A7 | Primary invasive adenocarcinoma, Gleason score 5-6 | 59 | W | pT2c | 3+3=6 | |||
Ca-A8 | Primary invasive adenocarcinoma, Gleason score 5-6 | 54 | W | pT2c | 3+3=6 | |||
Ca-A9 | Primary invasive adenocarcinoma, Gleason score 5-6 | 54 | B | pT2c | 3+3=6 | |||
Ca-A10 | Primary invasive adenocarcinoma, Gleason score 5-6 | 63 | W | pT2c | 3+3=6 | |||
Ca-B1 | Primary invasive adenocarcinoma, Gleason score 7 | 63 | W | pT2c | 3+4=7 | |||
Ca-B2 | Primary invasive adenocarcinoma, Gleason score 7 | 60 | B | pT3a | 3+4=7 | |||
Ca-B3 | Primary invasive adenocarcinoma, Gleason score 7 | 59 | W | pT2c | 3+4=7 | |||
Ca-B4 | Primary invasive adenocarcinoma, Gleason score 7 | 49 | B | pT2c | 3+4=7 | |||
Ca-B5 | Primary invasive adenocarcinoma, Gleason score 7 | 53 | W | pT2c | 3+4=7 | |||
Ca-B6 | Primary invasive adenocarcinoma, Gleason score 7 | 56 | B | pT2c | 3+4=7 | |||
Ca-B7 | Primary invasive adenocarcinoma, Gleason score 7 | 65 | W | pT2 | ||||
Ca-B8 | Primary invasive adenocarcinoma, Gleason score 7 | 62 | B | pT2b | 3+4=7 | |||
Ca-B9 | Primary invasive adenocarcinoma, Gleason score 7 | 67 | W | pT2c | 3+4=7 | |||
Ca-B10 | Primary invasive adenocarcinoma, Gleason score 7 | 52 | B | pT3a | 3+4=7 | |||
Ca-C1 | Primary invasive adenocarcinoma, Gleason score 8-10 | 58 | W | pT3b | 4+5=9 | |||
Ca-C2 | Primary invasive adenocarcinoma, Gleason score 8-10 | 67 | W | pT2c | 4+4=8 | |||
Ca-C3 | Primary invasive adenocarcinoma, Gleason score 8-10 | 64 | B | pT2c | 4+4=8 | |||
Ca-C4 | Primary invasive adenocarcinoma, Gleason score 8-10 | 62 | W | pT2c | 4+4=8 | |||
Ca-C5 | Primary invasive adenocarcinoma, Gleason score 8-10 | 70 | W | pT2c | 5+3=8 | |||
Ca-C6 | Primary invasive adenocarcinoma, Gleason score 8-10 | 64 | W | pT3b | 5+4=9 | |||
Ca-C7 | Primary invasive adenocarcinoma, Gleason score 8-10 | 69 | W | pT3b | 4+5=9 | |||
Ca-C8 | Primary invasive adenocarcinoma, Gleason score 8-10 | 56 | W | pT3b | 3+5=8 | |||
Ca-C9 | Primary invasive adenocarcinoma, Gleason score 8-10 | 71 | B | pT2c | 4+5=9 (TERTIARY 3) | |||
Ca-C10 | Primary invasive adenocarcinoma, Gleason score 8-10 | 64 | W | pT2 | 4+4=8 | |||
CON1 | Kidney (control tissue) | |||||||
CON2 | Placenta (control tissue) | |||||||
Race: W = white, B = black, O = other non-white | ||||||||
*American Joint Committee on Cancer Cancer Staging Manual, 7th Ed. | ||||||||
†2005 International Society of Urological Pathology Modified Gleason Grading System. |